This is not the most recent version of the article. View current version (4 AUG 2010)
Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)
Editorial Group: Cochrane Anaesthesia Group
Published Online: 15 APR 2009
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Afshari A, Brok J, Møller AM, Wetterslev J. Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007733. DOI: 10.1002/14651858.CD007733.
- Publication Status: Edited (no change to conclusions)
- Published Online: 15 APR 2009
This is not the most recent version of the article. View current version (04 AUG 2010)
This is the protocol for a review and there is no abstract. The objectives are as follows:
We will assess the benefits and harms of aerosolized prostacyclin for ALI/ARDS in adults and children as our primary objective. Furthermore, we will look at various outcomes, conduct subgroup and sensitivity analyses, examine the role of bias and apply trial sequential analyses (TSA) to examine the level of evidence.